Jiang Dianlu, Men Lijie, Wang Jianxiu, Zhang Yi, Chickenyen Sara, Wang Yinsheng, Zhou Feimeng
Department of Chemistry and Biochemistry, California State University, Los Angeles, Los Angeles, California 90032, USA.
Biochemistry. 2007 Aug 14;46(32):9270-82. doi: 10.1021/bi700508n. Epub 2007 Jul 18.
The binding stoichiometry between Cu(II) and the full-length beta-amyloid Abeta(1-42) and the oxidation state of copper in the resultant complex were determined by electrospray ionization-Fourier transform ion cyclotron resonance mass spectrometry (ESI-FTICR-MS) and cyclic voltammetry. The same approach was extended to the copper complexes of Abeta(1-16) and Abeta(1-28). A stoichiometric ratio of 1:1 was directly observed, and the oxidation state of copper was deduced to be 2+ for all of the complexes, and residues tyrosine-10 and methionine-35 are not oxidized in the Abeta(1-42)-Cu(II) complex. The stoichiometric ratio remains the same in the presence of more than a 10-fold excess of Cu(II). Redox potentials of the sole tyrosine residue and the Cu(II) center were determined to be ca. 0.75 and 0.08 V vs Ag/AgCl [or 0.95 and 0.28 V vs normal hydrogen electrode (NHE)], respectively. More importantly, for the first time, the Abeta-Cu(I) complex has been generated electrochemically and was found to catalyze the reduction of oxygen to produce hydrogen peroxide. The voltammetric behaviors of the three Abeta segments suggest that diffusion of oxygen to the metal center can be affected by the length and hydrophobicity of the Abeta peptide. The determination and assignment of the redox potentials clarify some misconceptions in the redox reactions involving Abeta and provide new insight into the possible roles of redox metal ions in the Alzheimer's disease (AD) pathogenesis. In cellular environments, the reduction potential of the Abeta-Cu(II) complex is sufficiently high to react with antioxidants (e.g., ascorbic acid) and cellular redox buffers (e.g., glutathione), and the Abeta-Cu(I) complex produced could subsequently reduce oxygen to form hydrogen peroxide via a catalytic cycle. Using voltammetry, the Abeta-Cu(II) complex formed in solution was found to be readily reduced by ascorbic acid. Hydrogen peroxide produced, in addition to its role in damaging DNA, protein, and lipid molecules, can also be involved in the further consumption of antioxidants, causing their depletion in neurons and eventually damaging the neuronal defense system. Another possibility is that Abeta-Cu(II) could react with species involved in the cascade of electron transfer events of mitochondria and might potentially sidetrack the electron transfer processes in the respiratory chain, leading to mitochondrial dysfunction.
通过电喷雾电离 - 傅里叶变换离子回旋共振质谱法(ESI - FTICR - MS)和循环伏安法测定了Cu(II)与全长β - 淀粉样蛋白Aβ(1 - 42)之间的结合化学计量比以及所得配合物中铜的氧化态。同样的方法被扩展应用于Aβ(1 - 16)和Aβ(1 - 28)的铜配合物。直接观察到化学计量比为1:1,并且推断所有配合物中铜的氧化态为2 +,在Aβ(1 - 42) - Cu(II)配合物中酪氨酸 - 10和甲硫氨酸 - 35残基未被氧化。在Cu(II)过量超过10倍的情况下,化学计量比保持不变。唯一酪氨酸残基和Cu(II)中心的氧化还原电位分别测定为相对于Ag/AgCl约0.75和0.08 V [或相对于标准氢电极(NHE)为0.95和0.28 V]。更重要的是,首次通过电化学方法生成了Aβ - Cu(I)配合物,并发现其催化氧气还原产生过氧化氢。三个Aβ片段的伏安行为表明,氧气向金属中心的扩散可能受Aβ肽的长度和疏水性影响。氧化还原电位的测定和归属澄清了涉及Aβ的氧化还原反应中的一些误解,并为氧化还原金属离子在阿尔茨海默病(AD)发病机制中的可能作用提供了新的见解。在细胞环境中,Aβ - Cu(II)配合物的还原电位足够高,能够与抗氧化剂(如抗坏血酸)和细胞氧化还原缓冲剂(如谷胱甘肽)反应,生成的Aβ - Cu(I)配合物随后可通过催化循环将氧气还原形成过氧化氢。通过伏安法发现,溶液中形成的Aβ - Cu(II)配合物很容易被抗坏血酸还原。产生的过氧化氢除了在破坏DNA、蛋白质和脂质分子方面发挥作用外,还可能参与抗氧化剂的进一步消耗,导致其在神经元中耗尽并最终损害神经元防御系统。另一种可能性是,Aβ - Cu(II)可能与参与线粒体电子传递事件级联反应的物质发生反应,并可能潜在地使呼吸链中的电子传递过程偏离正轨,导致线粒体功能障碍。